A personal critique: Evidence-based medicine, methodology, and ethics of randomised clinical trials

Critical Reviews in Oncology/Hematology

Volumn 40, Issue 2, 2001, Pages 125-130

  Zwitter, Matjaz ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Controlled clinical trials; Ethics; Evidence based medicine

Indexed keywords

ANALYTICAL PARAMETERS; CANCER PATIENT; CANCER RESEARCH; CANCER STATISTICS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; MEDICAL ETHICS; METHODOLOGY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PROFESSIONAL STANDARD; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CLINICAL TRIALS, PHASE II; EVIDENCE-BASED MEDICINE; HUMANS; MULTICENTER STUDIES; PATIENT SELECTION; PUBLISHING; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0034772736     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00138-X     Document Type: Review

References (12)

1. The pitfalls of narrative reviews in clinical medicine
2. Do authors of review articles use systematic methods to identify, assess and synthesize information?
3. Meta-analysis: Bias in location and selection of studies
4. A survey of the ethical considerations in randomised trials for lung cancer
5. Drug company 'suppressed' publication of research
6. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - Report on 3-year tumour control and normal tissue toxicity
7. Publication bias in clinical research
8. The fate of abstracts submitted to a cancer meeting: Factors which influence presentation and subsequent publication
9. Factors influencing publication of research results
10. Authors' criteria for selecting journals
11. Ethics of randomized clinical trials and the 'ALARA' approach
12. Improving the quality of reporting of randomized controlled trials: The CONSORT statement